De interés
16 sept 2020
Mylan and Development Partner, Synthon, Win Significant EPO Ruling Related to Copaxone® 40mg/mL
Decision clears legal pathway to expand access for patients living with multiple sclerosis in markets across Europe
más información
02 jul 2019
BC Partners to Acquire Synthon International Holding B.V.
BC Partners to Acquire Synthon International Holding B.V., a Global Market Leader in the Development of Complex Generics
más información
05 oct 2017
Regulatory Approval in Europe granted for Synthon’s glatiramer acetate 40 mg/ml
Synthon today announced that it has successfully concluded the decentralized procedures for glatiramer acetate 40 mg/ml pre-filled syringe for the treatment of relapsing forms of multiple sclerosis…
más información×
-
Synthon Argentina S.A.
Ruta 11 km 325, San Lorenzo Provincia de Sante Fe 2200
-
Synthon Chile Ltda.
El Castaño 145, Lampa, Santiago
-
Synthon Headquarters
Microweg 22, Nijmegen 6545 CL
-
Synthon Hispania S.L.
Castelló, 1, Poligono Las Salinas, Sant Boi de Llobregat 08830
-
Synthon Korea Co., Ltd.
A-821, RAEMIAN Yongsan The Central, Hangang-daero 95, Yongsan-gu, Seoul 04378
-
Synthon Mexico S.A. de C.V.
Periférico Sur 8565-A int 2,, Col. El Mante, Tlaquepaque, Jalisco 45609
-
Synthon Moscow (LLC)
6/2 Arbat Street, entrance 1, floor 2, room 3-7, Moscow 119019
-
Synthon Pharmaceuticals Inc.
1007 Slater Road, Suite 150, Durham, NC 27703
-
Synthon s.r.o.
Brnĕnská 32 /čp. 597, Blansko 678 01